Ionis Pharmaceuticals Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $1.47B | $683.3M |
| FY2020 | — | $743.3M | $397.7M |
| FY2021 | — | $771.7M | $869.2M |
| FY2022 | $1.18B | $572.9M | $276.5M |
| FY2023 | $1.24B | $386.7M | $399.3M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $1.47B | $683.3M |
| FY2020 | — | $743.3M | $397.7M |
| FY2021 | — | $771.7M | $869.2M |
| FY2022 | $1.18B | $572.9M | $276.5M |
| FY2023 | $1.24B | $386.7M | $399.3M |